Family-run Stilton maker on Brexit and copycats

'We want people to eat more cheese for breakfast'

Akebia Therapeutics, Inc. (AX9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

1.1500

-0.0300

(-2.54%)

At close: 08:04AM CEST

Loading interactive chart…

Simply Wall St.
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
The analysts covering Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) delivered a dose of negativity to shareholders today...
GuruFocus.com
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Insights into Akebia Therapeutics' Performance and Strategic Developments
Insider Monkey
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript May 9, 2024 Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.08775, expectations were $-0.09. AKBA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Akebia’s […]